Filing Details

Accession Number:
0001209191-10-007983
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-09 12:00:00
Reporting Period:
2010-02-05
Filing Date:
2010-02-09
Accepted Time:
2010-02-09 19:29:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343266 W Richard Pascoe Somaxon Pharmaceuticals, Inc.
3830 Valley Centre Drive, Suite 705-461
San Diego CA 92130
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-05 50,000 $1.23 50,000 No 4 M Direct
Common Stock Disposition 2010-02-05 62,000 $3.03 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2010-02-05 50,000 $0.00 50,000 $1.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
283,333 2018-08-10 No 4 M Direct
Footnotes
  1. This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Of the 62,000 shares sold, 50,000 shares were obtained upon the exercise of stock options.
  2. 185,183 shares of common stock subject to the option are vested and exercisable as of 2/5/2010 and approximately 9,259 shares vest and become exercisable on the first day of each month until June 1, 2011.
  3. Not applicable.